Schedule 13G ownership disclosure

ESPERION THERAPEUTICS, INC.

Common Stock, par value $0.001 per share · CUSIP: 29664W105

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Two Seas Capital LP

    Shares: 9,749,724 · Class: 4.7%

  • Two Seas Capital GP LLC

    Shares: 9,749,724 · Class: 4.7%

  • Sina Toussi

    Shares: 9,749,724 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-25-000555
Form type
SCHEDULE 13G/A
Filer
Esperion Therapeutics, Inc.
CIK
CIK 1434868
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub